International News

 
   Cost of Diabetes Drugs Hits the Roof
Even though the number of diabetes cases is on the rise across the globe, a group of Cardiff University suggests that the NHS is spending more than it     More..
   New Molecular Connection Between Obesity and Insulin Resistance Brings Hope of Safer Diabetes Drugs
Researchers have discovered a new molecular link between obesity and the way diabetes drugs work , which may lead to the development of safer medications for diabetes.     More..
   Your Pet Dog may be Benefited by Diabetes Monitoring Device
A continuous glucose-monitoring device - commonly used in humans with diabetes - is being used by a researcher to help treat dogs and other animals. "Our     More..
   Protein Important in Diabetes may also Play a Key Role in Heart Disease, Other Disorders
Genomics researchers have discovered that a protein implicated in diabetes may have an even broader role in disease, particularly in other metabolic disorders and heart disease.     More..
   Study Says Young Athletes With Diabetes can Still Perform
Diabetes affects performance of young athletes, but they can still manage a good performance, a new study has found. A participants' athletic prowess     More..

Recipe of the day - Adai

  Ingredients Wt.(gm) Measure
  Rice 30 2 tbsp
  Black gram dal 15 3 tsp
  Red gram dal 15 3 tsp
  Green gram dal 15 3 tsp
  Fenu greek seeds 12.5 2 tsp
  Oil 15 3 - 3/4  tsp
  Salt To taste
Soak rice dals fenugreeks seeds overnight. In the morning grind them coasery. Add all the spices. Spread ladleful of batter on a hot greased tawa (iron pan). Fry on slow fire on both sides. Cook the entire mixture this way.

Domestic News

Novo to launch anti-diabetes drug in India by 2010

The Economic Times: December 31, 2008
New Delhi: Danish pharmaceutical company Novo Nordisk plans to launch its anti-diabetes drug Liraglutide in India by 2010. The company claims that the drug, which helps faster control of blood sugar levels, would treat diabetes faster than insulin.

"Liraglutide has recently completed phase-III clinical trials successfully in India and we are planning to launch the drug by 2010 across the globe. We are working out the marketing strategy, which includes pricing of the medicine and promotional details," said a company spokesperson.

Liraglutide is an analog which has revealed better control of blood sugar compared with insulin therapy in diabetes patients. It reduces hypoglycaemia - the sudden lowering of blood sugar levels - by increasing insulin secretion and delaying gastric emptying.

"The medicine will be administered once daily and is expected to work quickly in comparison with insulin. The compound would act directly on betacells without going through the system and hence the speed of its action would increase. At present, there is no other 'once a daily' medicines available in Indian market for diabetes patients. We plan to promote our compound on these lines," said the spokesperson.